Norcoralydine
From DrugPedia: A Wikipedia for Drug discovery
| Norcoralydine
| |
| Systematic (IUPAC) name | |
| 2,3,10,11-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C21H25NO4 |
| Mol. mass | 355.4275 |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
[edit] Description
neuromuscular blocking agent; RN given refers to (S)-isomer; structure
[edit] General Properties
*Molecular Weight
355.4275
*Molecular Formula
C21H25NO4
*IUPAC NAME
2,3,10,11-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline
*Canonical Smiles
COC1=C(C=C2C3CC4=CC(=C(C=C4CN3CCC2=C1)OC)OC)OC
*Isomeric Smiles
N/A
*XLogP
2.4
*Topological Polar Surface Area
40.2
